[Off-label use of mycophenolate mofetil in immune-mediated diseases].

Alvaro Danza,Diego Graña,Cecilia Casas,Viviana Domínguez,Martín Rebella

Revista medica de Chile（2022）

引用 0|浏览5

暂无评分

摘要

Mycophenolate has a favorable response profile as a second line immunosuppressive agent. It is effective as a glucocorticoid sparing drug. The safety profile is also favorable as adverse effects were scanty and mild.

查看译文

关键词

Glucocorticoids, Immune System Diseases, Lupus Erythematosus, Systemic, Mycophenolic Acid

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要